Picardi A - Search Results

1

Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients.

De Vincentis A, Pennazza G, Santonico M, Vespasiani-Gentilucci U, Galati G, Gallo P, Zompanti A, Pedone C, Antonelli Incalzi R, Picardi A. De Vincentis A, et al. Among authors: picardi a. Liver Int. 2017 Feb;37(2):242-250. doi: 10.1111/liv.13214. Epub 2016 Aug 21. Liver Int. 2017. PMID: 27496750

2

[Consensus interferon: a new weapon in the treatment of chronic hepatitis C].

Vespasiani Gentilucci U, Picardi A. Vespasiani Gentilucci U, et al. Among authors: picardi a. Clin Ter. 2000 May-Jun;151(3):211-2. Clin Ter. 2000. PMID: 10958058 Italian. No abstract available.

3

[Ramipril and new therapeutic possibilities for ACE-inhibitors].

Vespasiani Gentilucci U, Picardi A. Vespasiani Gentilucci U, et al. Among authors: picardi a. Clin Ter. 2000 Jul-Aug;151(4):307-8. Clin Ter. 2000. PMID: 11107682 Italian. No abstract available.

4

[HCV-HIV co-infection: a new clinical challenge].

Picardi A, Vespasiani Gentilucci U. Picardi A, et al. Clin Ter. 2001 Nov-Dec;152(6):339-40. Clin Ter. 2001. PMID: 11865527 Italian. No abstract available.

5

Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor.

Vespasiani Gentilucci U, Santini D, Picardi A, Vincenzi B, Riva E, Bianchi A, Tonini G. Vespasiani Gentilucci U, et al. Among authors: picardi a. J Interferon Cytokine Res. 2002 Jun;22(6):683-8. doi: 10.1089/10799900260100178. J Interferon Cytokine Res. 2002. PMID: 12162879

6

The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

Santini D, Vespasiani Gentilucci U, Vincenzi B, Picardi A, Vasaturo F, La Cesa A, Onori N, Scarpa S, Tonini G. Santini D, et al. Among authors: picardi a. Ann Oncol. 2003 Oct;14(10):1468-76. doi: 10.1093/annonc/mdg401. Ann Oncol. 2003. PMID: 14504045 Free article. Review.

7

Iloprost: an adjunctive approach to chronic viral hepatitis treatment.

Zardi EM, Vespasiani Gentilucci U, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Afeltra A. Zardi EM, et al. Among authors: picardi a. Med Hypotheses. 2005;64(1):46-52. doi: 10.1016/j.mehy.2004.05.017. Med Hypotheses. 2005. PMID: 15533610

8

Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.

Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M. Vespasiani Gentilucci U, et al. Among authors: picardi a. Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71. doi: 10.1111/j.1365-2036.2005.02449.x. Aliment Pharmacol Ther. 2005. PMID: 15854167 Clinical Trial.

9

Diabetes in chronic liver disease: from old concepts to new evidence.

Picardi A, D'Avola D, Gentilucci UV, Galati G, Fiori E, Spataro S, Afeltra A. Picardi A, et al. Diabetes Metab Res Rev. 2006 Jul-Aug;22(4):274-83. doi: 10.1002/dmrr.636. Diabetes Metab Res Rev. 2006. PMID: 16506276 Review.

10

Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease.

Vespasiani Gentilucci U, Perrone G, Galati G, D'Avola D, Zardi EM, Rabitti C, Bianchi A, De Dominicis E, Afeltra A, Picardi A. Vespasiani Gentilucci U, et al. Among authors: picardi a. Histopathology. 2006 Jun;48(7):822-30. doi: 10.1111/j.1365-2559.2006.02429.x. Histopathology. 2006. PMID: 16722931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters